Evidence map›Paper›PMID 35081687›Full record

ArticleHaematologica2022

A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment.

Joanna S Yi, Tiffany M Chambers, Kelly D Getz, Tamara P Miller, Evanette Burrows, Marla H Daves, Philip J Lupo, Michael E Scheurer, Richard Aplenc, Karen R Rabin and 1 more

Abstract read
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joanna S YiBaylor College of Medicine, Texas Children's Cancer and Hematology Centers. Joanna.yi@bcm.edu.
Tiffany M ChambersBaylor College of Medicine, Texas Children's Cancer and Hematology Centers.
Kelly D GetzUniversity of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia.
Tamara P MillerEmory University School of Medicine, Children's Healthcare of Atlanta.
Evanette BurrowsUniversity of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia.
Marla H DavesBaylor College of Medicine, Texas Children's Cancer and Hematology Centers.
Philip J LupoBaylor College of Medicine, Texas Children's Cancer and Hematology Centers.
Michael E ScheurerBaylor College of Medicine, Texas Children's Cancer and Hematology Centers.
Richard AplencUniversity of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia.
Karen R RabinBaylor College of Medicine, Texas Children's Cancer and Hematology Centers.
Maria M GramatgesBaylor College of Medicine, Texas Children's Cancer and Hematology Centers.

Funding

PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAMK12CA090433 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CARL E ALLEN, Donald W. Parsons · 2002 to 2026
$18.5M
Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic LeukemiaP20CA262733 · NCI · BAYLOR COLLEGE OF MEDICINE · PI GRAMATGES, MARIA MONICA · 2021 to 2023
$3.2M
Improving Adverse Event Reporting on Cooperative Oncology Group TrialsK07CA211956 · NCI · EMORY UNIVERSITY · PI MILLER, TAMARA PORTER · 2017 to 2022
$916k
Early Treatment-Related Cardiotoxicity and Subsequent Outcomes in Pediatric Acute Myeloid Leukemia: an Assessment of Development, Progression and MitigationK01HL143153 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI GETZ, KELLY DIRINGER · 2018 to 2022
$716k
NCI NIH HHS K07 CA211956NCI NIH HHS K12 CA090433NCI NIH HHS P20 CA262733NHLBI NIH HHS K01 HL143153
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemical and Drug Induced Liver InjuryDrug-Related Side Effects and Adverse ReactionsPrecursor Cell Lymphoblastic Leukemia-LymphomaChildElectronicsHumans

Identifiers

PMID35081687
PMCPMC9052928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.